Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.

Source: [CNBC](https://www.cnbc.com/2026/10/24/biotech-stocks-drug-innovation-rally.html)

Sponsored